• 已选条件：
  • × Springer
  • × BMC Cardiovascular Disorder
  • × SGLT2 inhibitor
 全选  【符合条件的数据共：3条】

1 Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial [期刊论文]

来源：BMC Cardiovascular Disorders , 2021

作者:Shahram Arsang-Jang;Hassan Ahangar;Samin Ghanbari;等

关键词:SGLT2 inhibitor;Empagliflozin;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

2 Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study [期刊论文]

来源：BMC Cardiovascular Disorders , 2017

作者:Chim Lang;Allan Struthers;Alexander J.M. Brown;等

关键词:Diabetes;SGLT2 inhibitor;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

3 Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study [期刊论文]

来源：BMC Cardiovascular Disorders , 2017

作者:Chim Lang;Allan Struthers;Alexander J.M. Brown;等

关键词:Diabetes;SGLT2 inhibitor;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]